Current therapies and new developments in NASH
Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver
disease. There has been important progress in the field in recent years and the complexity of …
disease. There has been important progress in the field in recent years and the complexity of …
Current therapies and new developments in NASH
JF Dufour, QM Anstee, E Bugianesi, S Harrison… - Gut - pubmed.ncbi.nlm.nih.gov
Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver
disease. There has been important progress in the field in recent years and the complexity of …
disease. There has been important progress in the field in recent years and the complexity of …
Current therapies and new developments in NASH.
JF Dufour, Q Anstee, E Bugianesi, S Harrison… - Gut, 2022 - escholarship.org
Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver
disease. There has been important progress in the field in recent years and the complexity of …
disease. There has been important progress in the field in recent years and the complexity of …
[HTML][HTML] Current therapies and new developments in NASH
JF Dufour, QM Anstee, E Bugianesi, S Harrison… - Gut, 2022 - ncbi.nlm.nih.gov
Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver
disease. There has been important progress in the field in recent years and the complexity of …
disease. There has been important progress in the field in recent years and the complexity of …
Current therapies and new developments in NASH.
JF Dufour, QM Anstee, E Bugianesi, S Harrison… - Gut, 2022 - europepmc.org
Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver
disease. There has been important progress in the field in recent years and the complexity of …
disease. There has been important progress in the field in recent years and the complexity of …
[引用][C] Current therapies and new developments in NASH
JF Dufour, Q Anstee, E Bugianesi, S Harrison… - GUT, 2022 - iris.unito.it
Current therapies and new developments in NASH IRIS IRIS Home Sfoglia Macrotipologie
& tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN 1.IRIS 2.IRIS …
& tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN 1.IRIS 2.IRIS …
Current therapies and new developments in NASH
JF Dufour, QM Anstee, E Bugianesi, S Harrison… - Gut, 2022 - cir.nii.ac.jp
抄録< jats: p> Non-alcoholic steatohepatitis is becoming the most important aetiology for
advanced liver disease. There has been important progress in the field in recent years and …
advanced liver disease. There has been important progress in the field in recent years and …
Current therapies and new developments in NASH
JF Dufour, QM Anstee, E Bugianesi, S Harrison… - Gut, 2022 - search.proquest.com
Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver
disease. There has been important progress in the field in recent years and the complexity of …
disease. There has been important progress in the field in recent years and the complexity of …
[PDF][PDF] Current therapies and new developments in NASH
JF Dufour, QM Anstee, E Bugianesi, S Harrison… - scholar.archive.org
Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver
disease. There has been important progress in the field in recent years and the complexity of …
disease. There has been important progress in the field in recent years and the complexity of …
[PDF][PDF] Current therapies and new developments in NASH
JF Dufour, QM Anstee, E Bugianesi, S Harrison… - Gut, 2022 - gut.bmj.com
Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver
disease. There has been important progress in the field in recent years and the complexity of …
disease. There has been important progress in the field in recent years and the complexity of …